Current position:Home >Product >
1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-ylaMine hydrochloride, 98+% C17H19ClN6O2, MW: 374.83
1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-ylaMine hydrochloride, 98+% C17H19ClN6O2, MW: 374.83(1185313-21-6)
- Name: 1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-ylaMine hydrochloride, 98+% C17H19ClN6O2, MW: 374.83
- Synonyms:1-[1-(5-Nitro-2-pyridinyl)-1H-benzimidazol-2-yl]-4-piperidinamine hydrochloride;1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-ylaMine hydrochloride, 98+% C17H19ClN6O2, MW: 374.83
- Molecular Formula:C17H19ClN6O2
- Molecular Weight:374.83
- CAS Registry Number:1185313-21-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1185313-21-6 1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-ylaMine hydrochloride
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1185313-21-6 1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-ylaMine hydrochloride, 98+% C17H19ClN6O2, MW: 374.83
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-ylaMine hydrochloride, 98+% C17H19ClN6O2, MW: 374.83
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] - Hangzhou Hysen Pharma co.,Ltd.
Other Product
- 1185307-92-9/1-Pyridin-3-ylMethyl-piperidin-3-ol dihydrochloride, 98+% C11H18Cl2N2O, MW: 265.18
- 1185318-61-9/1-Pyridin-3-ylMethyl-piperidin-4-ol dihydrochloride, 98+% C11H18Cl2N2O, MW: 265.18
- 1185319-49-6/2-(Piperidin-4-yloxyMethyl)-pyridine dihydrochloride, 98+% C11H18Cl2N2O, MW: 265.18
- 1185312-66-6/1-Pyridin-2-ylMethyl-piperidin-3-ylaMine dihydrochloride, 98+% C11H19Cl2N3, MW: 264.19
- 939986-40-0/(1-Pyridin-2-ylMethyl-piperidin-3-yl)-Methanol, 98+% C12H18N2O, MW: 206.29
- 200113-14-0/1-Pyridin-2-ylMethyl-piperidin-3-ol, 98+% C11H16N2O, MW: 192.26
- 914641-83-1/1-Pyridin-2-ylMethyl-piperidin-4-ol, 98+% C11H16N2O, MW: 192.26
- 1185316-29-3/3-AMino-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72
- 1185309-64-1/4-AMino-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile hydrochloride, 98+% C11H15ClN4, MW: 238.72
- 939986-91-1/[1-(3-Chloro-quinoxalin-2-yl)-piperidin-3-yl]-carbaMic acid tert-butyl ester, 98+% C18H23ClN4O2, MW: 362.86
- 939986-90-0/[1-(3-Chloro-quinoxalin-2-yl)-piperidin-4-yl]-carbaMic acid tert-butyl ester, 98+% C18H23ClN4O2, MW: 362.86
- 939986-06-8/3-[(3-Chloro-quinoxalin-2-ylaMino)-Methyl]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C19H25ClN4O2, MW: 376.88
- 939986-05-7/4-[(3-Chloro-quinoxalin-2-ylaMino)-Methyl]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C19H25ClN4O2, MW: 376.88
- 939986-04-6/3-(3-Chloro-quinoxalin-2-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H23ClN4O2, MW: 362.86
- 939986-89-7/4-(3-Chloro-quinoxalin-2-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C18H23ClN4O2, MW: 362.86
- 353257-83-7/[1-(3-Chloro-quinoxalin-2-yl)-piperidin-3-yl]-Methanol, 98+% C14H16ClN3O, MW: 277.75
- 353257-75-7/1-(3-Chloro-quinoxalin-2-yl)-piperidin-3-ol, 98+% C13H14ClN3O, MW: 263.72
- 353257-77-9/1-(3-Chloro-quinoxalin-2-yl)-piperidin-4-ol, 98+% C13H14ClN3O, MW: 263.72
- 939986-88-6/1-(3-Chloro-quinoxalin-2-yl)-piperidine-4-carboxylic acid, 98+% C14H14ClN3O2, MW: 291.73
- 1185313-21-6/1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-ylaMine hydrochloride, 98+% C17H19ClN6O2, MW: 374.83
- 1146080-74-1/2-[2-(3-HydroxyMethyl-piperidin-1-yl)-benzoiMidazol-1-yl]-nicotinonitrile, 98+% C19H19N5O, MW: 333.39
- 1146080-64-9/{1-[1-(5-Nitro-pyridin-2-yl)-1H-benzoiMidazol-2-yl]-piperidin-4-yl}-carbaMic acid tert-butyl ester, 98+% C22H26N6O4, MW: 438.49
- 1082804-68-9/(2-Fluoro-phenyl)-(4-hydroxy-piperidin-1-yl)-Methanone, 98+% C12H14FNO2, MW: 223.25
- 1146080-22-9/2-Chloro-N-[1-(4-fluoro-benzoyl)-piperidin-4-yl]-acetaMide, 98+% C14H16ClFN2O2, MW: 298.75
- 851883-00-6/(4-Fluoro-phenyl)-(3-hydroxy-piperidin-1-yl)-Methanone, 98+% C12H14FNO2, MW: 223.25
- 1082882-95-8/(4-Fluoro-phenyl)-(4-hydroxy-piperidin-1-yl)-Methanone, 98+% C12H14FNO2, MW: 223.25
- 349128-53-6/(2-Fluoro-phenyl)-(3-hydroxyMethyl-piperidin-1-yl)-Methanone, 98+% C13H16FNO2, MW: 237.28
- 1146080-21-8/(2-Fluoro-phenyl)-(3-hydroxy-piperidin-1-yl)-Methanone, 98+% C12H14FNO2, MW: 223.25
- 1146080-07-0/3-[4-(Morpholine-4-carbonyl)-phenoxyMethyl]-piperidine-1-carboxylic acid tert-butyl ester, 98+% C22H32N2O5, MW: 404.51
- 939986-86-4/3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C12H15N3O, MW: 217.27